Abstract
To determine the rate and characteristics of gallstone recurrence after direct contact dissolution with methyltert-butyl ether, 60 consecutive patients were followed for up to 4.5 years (median 2.2 years) after complete disappearance of all stone residues and debris and cessation of adjuvant bile acid therapy. Initial gallstones had been multiple in all but four patients. Twenty-eight of the 60 patients developed recurrent gallstones. The cumulative risk of gallstone recurrence (actuarial analysis) was 23±6%, 34±7%, 55±8%, and 70±9% at one, two, three, and four years, respectively. The recurrent stones were usually multiple and small (6±4 mm). Gallstone recurrence was associated with recurrent biliary pain in two patients, one of whom developed acute cholecystitis. Recurrent stones were cleared completely by bile acid medication with or without shock-wave lithotripsy in 61±15% of patients at one year (actuarial analysis). In conclusion, gallstone recurrence after successful contact dissolution of multiple stones with methyltert-butyl ether has to be expected in a high percentage of patients. Most patients, however, remain free of biliary pain during long-term follow-up.
Similar content being viewed by others
References
Allen MJ, Borody TJ, Bugliosi TF, May GR, LaRusso NF, Thistle JL: Rapid dissolution of gallstones by methyltert-butyl ether. Preliminary observations. N Engl J Med 312:217–220, 1985
Van Sonnenberg E, Hofman AF, Neoptolemus J, Wittich GR, Princenthal RA, Wilson SW: Gallstone dissolution with methyltert-butyl ether via percutaneous cholecystostomy: success and caveats. Am J Roentengenol 146:865–867, 1986
Thistle JL, May GR, Bender CE, Williams HJ, LeRoy AJ, Nelson PE, Peine CJ, Petersen BT, McCullough JE: Dissolution of cholesterol gallbladder stones by methyltert-butyl ether administered by percutaneous transhepatic catheter. N Engl J Med 320:633–639, 1989
Holl J, Sauerbruch T, Sackmann M, Pauletzki J, Paumgartner G: Combined treatment of symptomatic gallbladder stones by extracorporeal shock wave lithotripsy (ESWL) and instillation of methyltert-butyl ether (MTBE). Dig Dis Sci 36:1097–1101, 1991
Leuschner U, Hellstern A, Schmidt K, Fischer H, Güldütuna S, Hübner K, Leuschner M: Gallstone dissolution with methyl tert-butyl ether in 120 patients: Efficacy and safety. Dig Dis Sci 36:193–199, 1991
Janowitz P, Schumacher KA, Swobodnik W, Kratzer W, Tudyka J, Wechsler J: Transhepatic topical dissolution of gallbladder stones with MTBE and EDTA. Dig Dis Sci 38:2121–2129, 1993
Neubrand M, Holl J, Sackmann M, Klueppelberg U, Pauletzki J, Paumgartner G, Sauerbruch T: Combination of extracorporeal shock wave lithotripsy and dissolution of gallbladder stones with methyltert-butyl ether: A randomized study. Hepatology 19:132–137, 1994
Leuschner U, Hellstern A, Ansell A, Gatzen M, Güldütuna S, Leuschner M: Manual and automatic gallstone dissolution with methyltert-butyl ether. Dig Dis Sci 39:1302–1305, 1994
Sauerbruch T, Holl J, Kruis W, Delius M, Paumgartner G: Dissolution of gallstones by methyltert-butyl ether. N Engl J Med 313:385–386, 1985
Soehendra N, Schulz H, Nam VC, Maydeo A, Schenkengel JP, Grimm H, Brueckner M, Eckmann B, Schreiber HW: ESWL and gallstone dissolution with MTBE via a naso-vesicular catheter. Endoscopy 22:176–179, 1990
Foerster EC, Matek W, Domschke W: Endoscopic retrograde cannulation of the gallbladder: Direct dissolution of gallstones. Gastrointest Endosc 36:444–450, 1990
Southern Surgeons Club: A prospective analysis of 1518 laparoscopic cholecystectomies. N Engl J Med 324:1073–1078, 1991
Marks JW, Lan SP, Steering Committee and National Cooperative Gallstone Study Group: Low-dose chenodiol to prevent gallstone recurrence after dissolution therapy. Ann Intern Med 100:376–381, 1984
Lanzini A, Jazrawi RP, Kupfer RM, Maugdal DP, Joseph AEA, Northfield TC: Gallstone recurrence after medical dissolution. An overestimated threat? J Hepatol 3:241–246, 1986
O'Donnell LDJ, Heaton KW: Recurrence and re-recurrence of gallstones after medical dissolution; long term follow-up. Gut 29:655–658, 1989
Villanova N, Bazzoli F, Taroni F, Frabboni R, Mazzella G, Festi D, Barbara L, Roda E: Gallstone recurrence after successful oral bile acid treatment. Gastroenterology 97:726–731, 1989
Petroni ML, Jazrawi RP, Goggin PM, Lanzini A, Fachinetti D, Heaton KW, Northfield TC: Characteristics of recurrent gallstones following non-surgical treatment: Implications for retreatment. Eur J Gastroenterol Hepatol 3:473–478, 1991
Hood KA, Gleeson D, Ruppin DC, Dowling RH, British-Belgian Gallstone Study Group: Gallstone recurrence and its prevention: The British/Belgian gallstone study group's post-dissolution trial. Gut 34:1277–1288, 1994
Pelletier G, Capdeville R, Mosnier H, Raymond JM, Delmont J, Moreaux J, Guivarch M, Amouretti M, Caroli FX, Levy VG, Etienne JP: Low early gallstone recurrence rate after extracorporeal lithotripsy in patients with solitary stones. J Hepatol 16:102–105, 1992
Schneider HT, Benninger J, Rabes U, Madani N, May A, Hahn EG, Ell C: Recurrent gallstone formation after successful extracorporeal shock wave lithotripsy. Am J Gastroenterol 88:1399–1405, 1993
Sackmann M, Niller H, Klueppelberg U, von Ritter C, Pauletzki J, Holl J, Berr F, Neubrand M, Sauerbruch T, Paumgartner G: Gallstone recurrence after shock wave therapy. Gastroenterology 106:225–230, 1994
Sackmann M, Pauletzki J, Sauerbruch T, Holl J, Schelling G, Paumgartner G: The Munich gallbladder lithotripsy study. Results of the first 711 patients. Ann Intern Med 114:290–296, 1991
Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481, 1958
McCullough JE, Stadheim LM, Reading CC, Petersen BT, Thistle JL: Gallstone recurrence after methyltert-butyl ether dissolution. Gastroenterology 322:A255, 1990
Jüngst D, Lang T, von Ritter C, Pratschke E, Paumgartner G: Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones. Hepatology 15:804–808, 1992
Van Sonnenberg E, Zakko S, Hofman AF, D'Agostino HB, Jinich H, Hoydt DB, Miyai K, Ramsby G, Moossa AR: Human gallbladder morphology after gallstone dissolution with methyltert-butyl ether. Gastroenterology 100:1718–1723, 1991
Berr F, Mayer M, Sackmann M, Sauerbruch T, Holl J, Paumgartner G: Pathogenetic factors in early recurrence of cholesterol gallstones. Gastroenterology 106:215–224, 1994
Northfield TC, Petroni ML, Jazrawi RP: Management of recurrent stones. In: G Paumgartner, T Sauerbruch, M Sackmann, HJ Burhenne (eds). Biliary Lithotripsy and Related Techniques for Gallstone Treatment. St. Louis, Mosby Year Book, 1991, pp 243–245
Pomare EW, Heaton KW, Low-Beer TS, Espiner HJ: The effect of wheat bran upon bile salt metabolism and upon the lipid composition of bile in gallstone patients. Am J Dig Dis 21:521–526, 1976
Thornton JR, Emmet PM, Heaton KW: Diet and gallstones: Effects of refined and unrefined carbohydrate diets on bile cholesterol saturation and bile acid metabolism. Gut 24:2–6, 1983
Broomfield PH, Chopra R, Sheinbaum R, Bonorris GG, Silverman A, Schoenfield LJ, Marks JW: Effects of ursodeoxycholic acid and aspirin on the prevention of the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med 319:1567–1572, 1988
Hofmann AF: Primary and secondary prevention of gallstone disease. Implications for patient management and research priorities. Am J Surg 165:541–548, 1993
Adamek HE, Buttmann A, Riemann JF: Can aspirin prevent gallstone recurrence after successful extracorporeal shock wave lithotripsy. Scand J Gastroenterol 29:355–359, 1994
Lee SP, Carey MC, LaMont JT: Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 211:1429–1431, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pauletzki, J., Holl, J., Sackmann, M. et al. Gallstone recurrence after direct contact dissolution with methyltert-butyl ether. Digest Dis Sci 40, 1775–1781 (1995). https://doi.org/10.1007/BF02212701
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02212701